Clinical trial
Aliskiren Combined With Losartan in Immunoglobulin A Nephropathy: an Open-label Pilot Study
NCT00922311 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aliskiren Combined With Losartan in Immunoglobulin A Nephropathy: an Open-label Pilot Study
- Lead sponsor
- The University of Hong Kong
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2009
- Completion date
- December 31, 2010
- Enrollment
- 25 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
iga nephropathy